BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11932897)

  • 1. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma.
    Tachibana M; Shibakita M; Ohno S; Kinugasa S; Yoshimura H; Ueda S; Fujii T; Rahman MA; Dhar DK; Nagasue N
    Cancer; 2002 Apr; 94(7):1955-60. PubMed ID: 11932897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.
    Wang Z; He W; Yang G; Wang J; Wang Z; Nesland JM; Holm R; Suo Z
    BMC Cancer; 2010 Jul; 10():352. PubMed ID: 20602752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.
    Tsutsui S; Inoue H; Yasuda K; Suzuki K; Higashi H; Era S; Mori M
    Oncology; 2005; 68(4-6):398-404. PubMed ID: 16020969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma.
    Lu J; Pan Y; Xia X; Gu Y; Lei Y
    Biomed Res Int; 2015; 2015():417210. PubMed ID: 26357655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
    Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
    Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.
    Nozoe T; Korenaga D; Kabashima A; Ohga T; Saeki H; Sugimachi K
    Clin Cancer Res; 2002 Mar; 8(3):817-22. PubMed ID: 11895914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
    Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
    J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN/MMAC1 expression in esophageal squamous cell carcinomas.
    Ding Y; Shimada Y; Kano M; Itami A; Kawabe A; Maeda M; Li Z; Hong T; Sato F; Kaganoi J; Imamura M
    Int J Oncol; 2000 Oct; 17(4):695-9. PubMed ID: 10995879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.
    Zhang C; Xue G; Bi J; Geng M; Chu H; Guan Y; Wang J; Wang B
    Tumour Biol; 2014 Jan; 35(1):73-80. PubMed ID: 23873103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of PTEN expression as a prognostic marker for tongue cancer.
    Lee JI; Soria JC; Hassan KA; El-Naggar AK; Tang X; Liu DD; Hong WK; Mao L
    Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1441-5. PubMed ID: 11735811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma.
    Sudo T; Iwaya T; Nishida N; Sawada G; Takahashi Y; Ishibashi M; Shibata K; Fujita H; Shirouzu K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S324-35. PubMed ID: 22644514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.
    Tateno T; Ueno S; Hiwatashi K; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Sakoda M; Kubo F; Ishigami S; Shinchi H; Natsugoe S
    Ann Surg Oncol; 2009 Feb; 16(2):440-6. PubMed ID: 19023628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
    Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma.
    Megumi K; Ishigami S; Uchikado Y; Kita Y; Okumura H; Matsumoto M; Uenosono Y; Arigami T; Kijima Y; Kitazono M; Shinchi H; Ueno S; Natsugoe S
    Ann Surg Oncol; 2012 Jun; 19(6):2066-71. PubMed ID: 21913019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer.
    Li P; Mao WM; Zheng ZG; Dong ZM; Ling ZQ
    Dig Dis Sci; 2013 Dec; 58(12):3483-93. PubMed ID: 24221338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
    Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
    Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.